1... a working tumor chemosensitivity assay (tca) could be of immense benefit to the pharmaceutical...
TRANSCRIPT
![Page 1: 1... A working tumor chemosensitivity assay (TCA) could be of immense benefit to the pharmaceutical industry, oncologists and their patients (Cree and](https://reader036.vdocuments.mx/reader036/viewer/2022072005/56649ccd5503460f949976aa/html5/thumbnails/1.jpg)
![Page 2: 1... A working tumor chemosensitivity assay (TCA) could be of immense benefit to the pharmaceutical industry, oncologists and their patients (Cree and](https://reader036.vdocuments.mx/reader036/viewer/2022072005/56649ccd5503460f949976aa/html5/thumbnails/2.jpg)
1... A working tumor chemosensitivity assay (TCA) could be of immense benefit to the pharmaceutical industry, oncologists and their patients (Cree and Kurbacher, 1997)
2... ATP-TCA can be used to select patients who might benefit from specific chemotherapeutic agents alone or in combination (Cree et al, 1999)
Literature...
Continued...
![Page 3: 1... A working tumor chemosensitivity assay (TCA) could be of immense benefit to the pharmaceutical industry, oncologists and their patients (Cree and](https://reader036.vdocuments.mx/reader036/viewer/2022072005/56649ccd5503460f949976aa/html5/thumbnails/3.jpg)
Results of Chemotherapy guided by the ATP-TCA
1... Retrospective clinical correlation in breast carcinoma (Cree et al, 1996): 97% assay evaluability, 76% accuracy, 27% improvement in clinical response rate
2... A greater benefit with regard to both ORR and PFS in platinum refractory patients (Kurbacher et al, 1998): Overall survival, 97 weeks / 69 weeks; Response rate, 64% / 37%
![Page 4: 1... A working tumor chemosensitivity assay (TCA) could be of immense benefit to the pharmaceutical industry, oncologists and their patients (Cree and](https://reader036.vdocuments.mx/reader036/viewer/2022072005/56649ccd5503460f949976aa/html5/thumbnails/4.jpg)
TWO GREAT BENEFITS OBTAINED FROM CHEMOSENSITIVITY TESTING
• Exclusion of chemotherapeutic agents which are not likely to be effective, thereby avoidance of their potential toxicity
• Selection of chemotherapeutic agents with the greatest likelihood of clinical effectiveness for improved response rates and prolonged survival
![Page 5: 1... A working tumor chemosensitivity assay (TCA) could be of immense benefit to the pharmaceutical industry, oncologists and their patients (Cree and](https://reader036.vdocuments.mx/reader036/viewer/2022072005/56649ccd5503460f949976aa/html5/thumbnails/5.jpg)
Briefly...
• It is considered that defective apoptosis is a feature of malignant development
• Enhancing apoptosis in malignancies is to be aimed
• Detection of apoptosis-related proteins may be of importance in the prediction of response to chemo- or radio-therapy as well as of survival rates
• Chemosensitivity testing seems to provide more realistic approaches to the treatment of malignancies, letting oncologists design the chemotherapy regimen on the basis of patient-specificity